Herbal Medicine in Ischemic Stroke: Challenges and Prospective

Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke 2009;40:2068–2072.

Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med 2011;17:796–808.

Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010;67:181–198.

Yenari MA, Han HS. Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat Rev Neurosci 2012;13:267–278.

Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia—the ischemic penumbra. Stroke 1981;12:723–725.

Bandera E, Botteri M, Minelli C, Sutton A, Abrams KR, Latronico N. Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a systematic review. Stroke 2006;37:1334–1339.

Fisher M. The ischemic penumbra: identification, evolution and treatment concepts. Cerebrovasc Dis 2004;17(Suppl 1):1–6.

Segura T, Calleja S, Jordan J. Recommendations and treatment strategies for the management of acute ischemic stroke. Expert Opin Pharmacother 2008;9:1071–1085.

Feigin VL. Herbal medicine in stroke: does it have a future? Stroke 2007;38:1734–1736.

Gong X, Sucher NJ. Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development. Trends Pharmacol Sci 1999;20:191–196.

Gaire BP, Moon SK, Kim H. Scutellaria baicalensis in stroke management: nature’s blessing in traditional Eastern medicine. Chin J Integr Med 2014;20:712–720.

Ho JW, Cheung MW, Yu VW. Active phytochemicals from Chinese herbs as therapeutic agents for the heart. Cardiovasc Hematol Agents Med Chem 2012;10:251–255.

Lozoya X. Two decades of Mexican ethnobotany and research in plant drugs. Ciba Found Symp 1994;185:130–152.

Green AR. Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly. Br J Pharmacol 2008;153(Suppl 1):S325–S338.

Shankar K, Liao LP. Traditional systems of medicine. Phys Med Rehabil Clin N Am 2004;15:725–747.

Kiefer D, Pitluk J, Klunk K. An overview of CAM: components and clinical uses. Nutr Clin Pract 2009;24:549–559.

Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov 2015;14:111–129.

Iriti M, Vitalini S, Fico G, Faoro F. Neuroprotective herbs and foods from different traditional medicines and diets. Molecules 2010;15:3517–3555.

Wu PF, Zhang Z, Wang F, Chen JG. Natural compounds from traditional medicinal herbs in the treatment of cerebral ischemia/reperfusion injury. Acta Pharmacol Sin 2010;31:1523–1531.

Gaire BP, Subedi SL. Medicinal plant diversity and their pharmacological aspects of Nepal Himalayas. Pharmacogn J 2011;2:6–17.

Ernst E. Herbal medicines: balancing benefits and risks. Novartis Found Symp 2007;282:154–172, 212–218.

Benzie IFF, Wachtel-Galor S, eds. Herbal medicine: biomolecular and clinical aspects. 2nd ed. Boca Raton (FL): CRC Press/Taylor & Francis; 2011.

Mantz J, Degos V, Laigle C. Recent advances in pharmacologic neuroprotection. Eur J Anaesthesiol 2010;27:6–10.

Ernst E, Pittler MH. Risks associated with herbal medicinal products. Wien Med Wochenschr 2002;152:183–189.

Capasso R, Izzo AA, Pinto L, Mascolo N. Phytotherapy and quality of herbal medicines. Fitoterapia 2000;71(Suppl 1):S58–S65.

Jordan SA, Cunningham DG, Marles RJ. Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment. Toxicol Appl Pharmacol 2010;243:198–216.

Ernst E. Risks of herbal medicinal products. Pharmacoepidemiol Drug Saf 2004;13:767–771.

Pinn G. Adverse effects associated with herbal medicine. Aust Fam Physician 2001;30:1070–1075.